Daniel Tardiff
Fortune : - $ au 31/05/2026
Fortune : - $ au 31/05/2026
Daniel Tardiff is currently Chief Scientific Officer at CAMP4 Therapeutics Corp.
Dr. Tardiff worked as Research Head at Yumanity Therapeutics, Inc. Dr. Tardiff earned a doctorate from Brandeis University and completed undergraduate studies at Stonehill College, Inc.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CAMP4 THERAPEUTICS CORPORATION | Directeur Technique/Scientifique/R&D | 01/10/2025 |
| Sociétés | Poste | Fin |
|---|---|---|
| YUMANITY THERAPEUTICS | Directeur Technique/Scientifique/R&D | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Brandeis University
Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stonehill College, Inc.
Stonehill College, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Camp4 Therapeutics Corp.
Camp4 Therapeutics Corp. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in the development of regulatory RNA-based therapeutics | Health Technology |
Yumanity Therapeutics, Inc.
Yumanity Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national